Tiagabine Hydrochloride Patent Expiration
Tiagabine Hydrochloride was first introduced by Cephalon Inc
Tiagabine Hydrochloride Patents
Given below is the list of patents protecting Tiagabine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gabitril | US5958951 | Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
Jun 10, 2017
(Expired) | Cephalon |
| Gabitril | US5866590 | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation |
Apr 29, 2016
(Expired) | Cephalon |
Tiagabine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Tiagabine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Tiagabine Hydrochloride. The first generic version for Tiagabine Hydrochloride was by Sun Pharmaceutical Industries Ltd and was approved on Nov 4, 2011. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Nov 16, 2021.
Given below is the list of companies who have filed for Tiagabine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 4 different strengths of generic version for Tiagabine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Discontinued | ORAL | N/A | Dec 8, 2017 |
| 4MG | tablet | Discontinued | ORAL | N/A | Dec 8, 2017 |
| 12MG | tablet | Discontinued | ORAL | N/A | Dec 8, 2017 |
| 16MG | tablet | Discontinued | ORAL | N/A | Dec 8, 2017 |
2. MSN
Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Tiagabine Hydrochloride. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Nov 16, 2021 |
| 4MG | tablet | Prescription | ORAL | AB | Nov 16, 2021 |
| 12MG | tablet | Prescription | ORAL | AB | Nov 16, 2021 |
| 16MG | tablet | Prescription | ORAL | AB | Nov 16, 2021 |
Manufacturing Plant Locations New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||
| United States |
| |||||||||||||||||||||
3. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Tiagabine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Nov 4, 2011 |
| 4MG | tablet | Prescription | ORAL | AB | Nov 4, 2011 |
4. WILSHIRE PHARMS INC
Wilshire Pharmaceuticals Inc has filed for 4 different strengths of generic version for Tiagabine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Discontinued | ORAL | N/A | Oct 13, 2017 |
| 4MG | tablet | Discontinued | ORAL | N/A | Oct 13, 2017 |
| 12MG | tablet | Discontinued | ORAL | N/A | Oct 13, 2017 |
| 16MG | tablet | Discontinued | ORAL | N/A | Oct 13, 2017 |